EUVIMEDEUVIMED entdecken
Open Access · CC0

Mitochondrial hyperactivity and reactive oxygen species drive innate immunity to the yellow fever virus-17D live-attenuated vaccine

Samantha G Muccilli, Benjamin Schwarz, Byron Shue, Forrest Jessop, Jeffrey G Shannon, Charles L Larson, Adam Hage, Seon-Hui Hong, Eric Bohrnsen, Thomas Hsu, Alison W Ashbrook, Gail L Sturdevant und 9 weitere

PLOS Pathogens · 21.04.2025 · 21 (4) · e1012561

DOI: 10.1371/journal.ppat.1012561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 21.04.2025. Verfasst von Samantha G Muccilli und 20 weiteren Autor:innen. Beteiligte Einrichtung: Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Mont…. Hauptthemen laut MEDLINE: Immunity, Innate, Reactive Oxygen Species, Mitochondria, Yellow Fever Vaccine. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The yellow fever virus 17D (YFV-17D) live attenuated vaccine is considered one of the most successful vaccines ever generated associated with high antiviral immunity, yet the signaling mechanisms that drive the response in infected cells are not understood. Here, we provide a molecular understanding of how metabolic stress and innate immune responses are linked to drive type I IFN expression in response to YFV-17D infection. Comparison of YFV-17D replication with its parental virus, YFV-Asibi, and a related dengue virus revealed that IFN expression requires RIG-I-Like Receptor signaling through MAVS, as expected. However, YFV-17D uniquely induces mitochondrial respiration and major metabolic perturbations, including hyperactivation of electron transport to fuel ATP synthase. Mitochondrial hyperactivity generates reactive oxygen species (ROS) including peroxynitrite, blocking of which abrogated MAVS oligomerization and IFN expression in non-immune cells without reducing YFV-17D replication. Scavenging ROS in YFV-17D-infected human dendritic cells increased cell viability yet globally prevented expression of IFN signaling pathways. Thus, adaptation of YFV-17D for high growth imparts mitochondrial hyperactivity to meet energy demands, resulting in generation of ROS as the critical messengers that convert a blunted IFN response into maximal activation of innate immunity essential for vaccine effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateReactive Oxygen SpeciesMitochondriaYellow Fever VaccineYellow fever virusYellow FeverHumansVaccines, AttenuatedAnimalsVirus ReplicationSignal TransductionDendritic Cells

Substanzen

Reactive Oxygen SpeciesYellow Fever VaccineVaccines, Attenuated

Autor:innen und Institutionen

  • Innate Immunity and Pathogenesis Section, Laboratory of Neurological Infections and Immunity, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America.
  • Cellular Biology Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, United States of America.
  • Research Technologies Branch, NIAID, NIH, Hamilton, Montana, United States of America.
  • Immunity to Pulmonary Pathogens Section, Laboratory of Bacteriology, NIAID, NIH, Hamilton, Montana, United States of America.
  • Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.
  • Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.

ORCID-Profile: Sonja M Best

Förderung

  • NIAID NIH HHS
  • NIH

Zitieren

APA

Muccilli, S. G., Schwarz, B., Shue, B., Jessop, F., Shannon, J. G., Larson, C. L., Hage, A., Hong, S. H., Bohrnsen, E., Hsu, T., Ashbrook, A. W., Sturdevant, G. L., Robertson, S. J., Guarnieri, J. W., Lack, J., Wallace, D. C., Bosio, C. M., MacDonald, M. R., Rice, C. M., …, & Best, S. M. (2025). Mitochondrial hyperactivity and reactive oxygen species drive innate immunity to the yellow fever virus-17D live-attenuated vaccine. PLOS Pathogens, 21(4), e1012561. https://doi.org/10.1371/journal.ppat.1012561

Vancouver

Muccilli SG, Schwarz B, Shue B, Jessop F, Shannon JG, Larson CL, et al. Mitochondrial hyperactivity and reactive oxygen species drive innate immunity to the yellow fever virus-17D live-attenuated vaccine. PLOS Pathogens. 2025;21(4):e1012561. doi:10.1371/journal.ppat.1012561

BibTeX
@article{Muccilli2025,
  author = {Muccilli, Samantha G and Schwarz, Benjamin and Shue, Byron and Jessop, Forrest and Shannon, Jeffrey G and Larson, Charles L and Hage, Adam and Hong, Seon-Hui and Bohrnsen, Eric and Hsu, Thomas and Ashbrook, Alison W and Sturdevant, Gail L and Robertson, Shelly J and Guarnieri, Joseph W and Lack, Justin and Wallace, Douglas C and Bosio, Catharine M and MacDonald, Margaret R and Rice, Charles M and Yewdell, Jonathan W and Best, Sonja M},
  title = {Mitochondrial hyperactivity and reactive oxygen species drive innate immunity to the yellow fever virus-17D live-attenuated vaccine},
  journal = {PLOS Pathogens},
  year = {2025},
  volume = {21},
  number = {4},
  pages = {e1012561},
  doi = {10.1371/journal.ppat.1012561}
}
Kostenlos starten →